Hospira Recalls Lactated Ringer's and Dextrose Injections

Hospira issued a voluntary recall of one lot of Lactated Ringer’s and 5% Dextrose Injection, amid concerns of a possible mold contamination that may cause a life-threatening blood infection in patients, according to the Food and Drug Administration (FDA).

Though no reports of adverse effects have been reported to date, the FDA says the injections are being recalled based on a consumer report where a leak was noticed in the primary container for the product.

Septicemia — blood stream infections — can also lead to life-threatening septic shock. The symptoms include fever, shortness of breath, fast heart rate, and a feeling of illness, nausea, and vomiting.

The recall affects USP, 1000 mL, Flexible Container, NDC 0409-7929-09, with an expiration date of 1 December 2013, distributed in the U.S. except for Alaska, from January 2012 and June 2012. Mold-like particle matter was observed in a sample of the affected lot.

Hospira has initiated an investigation to determine the root cause of the problem and corrective and preventive actions.

The FDA has asked consumers to discontinue use of the product and contact Stericycle for replacement of the product.

If you or a loved one has been harmed by a dangerous drug, contact Sokolove Law today for a free legal consultation and to find out if a dangerous drug lawyer may be able to help you.

Tags: